Skip to main content
ANHL1522: Durable Immunity to EBV post Rituximab and Third Party LMP-specific T-cells: A Children's Oncology Group Study.
Intensive Care Risk and Long-Term Outcomes in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients.
Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis.
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study.
Opposing Effects of KDM6A and JDP2 on Glucocorticoid Sensitivity in T-ALL.
Combinatorial targeting of epigenome-modifying enzymes with small molecule drugs synergistically increases HbF.
HLH-like toxicities predict poor survival following use of tisagenlecleucel in children and young adults with B-ALL.
Histone Deacetylase-6 Modulates the Effects of 4oC Platelets on Vascular Endothelial Permeability.
The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry.
Higher doses of tisagenlecleucel associate with improved outcomes: a report from the pediatric real-world CAR consortium.